Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
RFL Quote, Financials, Valuation and Earnings
Last price:
$2.22
Seasonality move
:
-7.22%
Day range:
$2.09 - $2.28
52-week range:
$1.28 - $3.19
Dividend yield:
0%
P/E ratio:
17.20x
P/S ratio:
72.00x
P/B ratio:
0.98x
Volume:
96.3K
Avg. volume:
426.7K
1-year change:
50.99%
Market cap:
$67.9M
Revenue:
$637K
EPS (TTM):
-$2.11
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Rafael Holdings has -- downside to fair value with a price target of -- per share.
RFL vs. S&P 500
-
Over the past 5 trading days, Rafael Holdings has overperformed the S&P 500 by 12.7% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Rafael Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Rafael Holdings has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Rafael Holdings reported revenues of $77K.
Earnings Growth
-
Rafael Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Rafael Holdings reported earnings per share of -$0.19.
Enterprise value:
25.2M
EV / Invested capital:
--
Price / LTM sales:
72.00x
EV / EBIT:
--
EV / Revenue:
35.68x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-2.90x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$477K
Return On Assets:
-53.07%
Net Income Margin (TTM):
-7148.16%
Return On Equity:
-58.82%
Return On Invested Capital:
-57.31%
Operating Margin:
-4661.04%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $285K | $275K | $706K | $68K | $77K | |
| Gross Profit | -- | $275K | $477K | $68K | $39K | |
| Operating Income | -$18.9M | -$11.3M | -$14.6M | -$3.1M | -$3.6M | |
| EBITDA | -$19M | $2.4M | -$83.4M | $6.1M | -$5.1M | |
| Diluted EPS | -$0.60 | $0.10 | -$2.11 | $0.25 | -$0.19 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.7M | $71.5M | $90M | $75.1M | $65.8M | |
| Total Assets | $146.2M | $122.6M | $98.6M | $106.1M | $83M | |
| Current Liabilities | $10.8M | $22.8M | $2M | $3.3M | $7.1M | |
| Total Liabilities | $10.9M | $22.9M | $2M | $3.9M | $10.5M | |
| Total Equity | $135.4M | $99.7M | $96.5M | $102.3M | $72.6M | |
| Total Debt | -- | $14.8M | -- | $1.7M | $2.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$20.4M | -$7.4M | -$8.5M | -$2.5M | -$2.3M | |
| Cash From Investing | -$30.4M | $5.2M | $49.8M | -$2.8M | $42.5M | |
| Cash From Financing | -$9.2M | -$186K | -$129K | -$932K | -$27K | |
| Free Cash Flow | -$20.4M | -$7.4M | -$8.7M | -$2.5M | -$2.3M | |
RFL
Sector
Market Cap
$67.9M
$34.4M
Price % of 52-Week High
66.46%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-0.93%
-1.01%
1-Year Price Total Return
53.62%
-37.36%
Beta (5-Year)
0.971
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.10
200-day SMA
Buy
Level
$1.85
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$1.88
Relative Strength Index (RSI14)
Buy
Level
62.77
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-48.5956
50-day SMA
Buy
Level
$1.72
MACD (12, 26)
Buy
Level
0.60
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.3082)
Sell
CA Score
(Annual)
Level (-1.565)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (10.252)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
Stock Forecast FAQ
In the current month, RFL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RFL average analyst price target in the past 3 months is --.
-
Where Will Rafael Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Rafael Holdings share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Rafael Holdings?
Analysts are divided on their view about Rafael Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Rafael Holdings is a Sell and believe this share price will rise from its current level to --.
-
What Is Rafael Holdings's Price Target?
The price target for Rafael Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is RFL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Rafael Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of RFL?
You can purchase shares of Rafael Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Rafael Holdings shares.
-
What Is The Rafael Holdings Share Price Today?
Rafael Holdings was last trading at $2.22 per share. This represents the most recent stock quote for Rafael Holdings. Yesterday, Rafael Holdings closed at $2.28 per share.
-
How To Buy Rafael Holdings Stock Online?
In order to purchase Rafael Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
93
EXOD alert for Jul 18
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
